Glioblastoma Awareness Day: July 17, 2024 #GBMDay The Neosoma team recognizes all the people affected by this disease: patients, caregivers, and family members. We appreciate the dedication and commitment of the clinicians who care for these patients as well as the scientists and researchers pursuing improved treatments. Neosoma’s mission is to advance brain tumor clinical care and clinical trials, by building a portfolio of AI-based technologies that provide clinicians with greater insights to help guide treatment techniques, clinical management decisions as well as support clinical trials for the development of new treatment options in the hope to one day find a cure. National Brain Tumor Society American Brain Tumor Association Malnati Brain Tumor Institute at Northwestern UofL Health Miami Cancer Institute Mount Sinai Health System UCLA Brain Tumor Imaging Laboratory UCSF Department of Radiology & Biomedical Imaging Nuance Communications
Neosoma Inc.
Medical Equipment Manufacturing
Boston, MA 742 followers
Advancing Brain Tumor Care and Clinical Trials
About us
At Neosoma, we stand at the crossroads where cutting-edge science meets compassionate care. Our mission is to design and deploy clinician-centric, A.I. powered neurodiagnostic solutions. Our advanced tools cater to neuroradiologists, radiation oncologists, neurologists, neurosurgeons, and neuroscience researchers. Our prime objective is to enhance the research, diagnosis, treatment, and clinical trials pertaining to brain cancers. Our patented, FDA-approved technology offerings bridge the gap between raw data and actionable insights. They ensure the right, precise information is at the physician's fingertips exactly when it's needed. Moreover, our solutions integrate smoothly within existing workflows and facilitate seamless collaboration amongst all the professionals engaged in the care of brain cancer patients. At Neosoma, we draw our strength from the seasoned practicing physicians and software industry veterans who form our leadership. This unique blend enables us to develop world-class software that prioritizes the needs of both patients and physicians. We firmly believe this patient-centric, physician-first approach will trigger the most substantial positive impact on our patients' health outcomes and resonate profoundly within our community. Our collaborations extend to some of the most progressive and innovative health systems across the US. We invite you to explore how our FDA-approved technologies can catalyze the growth and effectiveness of your NeurOnc. Practice. Please get in touch to learn more about the difference Neosoma can make!
- Website
-
http://www.neosomainc.com
External link for Neosoma Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Boston, MA
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
Boston, MA 02101, US
-
Groton, MA, US
-
Bern , CH
Employees at Neosoma Inc.
-
Arlen Meyers, MD, MBA
President and CEO, Society of Physician Entrepreneurs, another lousy golfer, terrible cook, friction fixer
-
Ken Kolodziej
CEO at Neosoma, Inc.
-
Richard Stark
Principal, OPTO,LLC., Strategic Advisor, Board Member- MedTech, Software, Digital Health & Medical Informatics (ML/AI)
-
Debbie Millin
CEO | Board Member | Entrepreneur | Speaker | HBS | debbiemillin.com | FemaleExecFavs.com